Table 1

Response to therapy and outcome according to IDH2 genotype

5 years
10 years
Univariable analysis
IDH1/2WTIDH1MUTIDH2R140IDH2R172IDH1/2WTIDH1MUTIDH2R140IDH2R1724-way POR or HR (95% CI) (IDH2R140 vs IDH2R172 vs IDH1/2WT)
CR, % 75 81 88 48 NA NA NA NA < .0001 R140: OR = 0.41 (0.23-0.73) R172: OR = 3.15 (1.50-6.59) P < .0001 
CR/CRi, % 82 81 92 79 NA NA NA NA .03 R140: OR = 0.40 (0.20-0.81) R172: OR = 1.23 (0.49-3.05) P = .01 
RD, % 11 11 14 NA NA NA NA .11 R140: OR = 0.38 (0.15-0.96) R172: OR = 1.34 (0.46-3.90) P = .05 
ID, % NA NA NA NA .5 R140: OR = 0.50 (0.18-1.38) R172: OR = 1.01 (0.24-4.33) P = .3 
OS, % 37 38 57 24 33 34 46 .001 R140: HR = 0.65 (0.50-0.84) R172: HR = 1.40 (0.95-2.07) P = .0004 
CIR, % 50 49 28 70 51 55 35 70 .0003 R140: HR = 0.53 (0.38-0.74) R172: HR = 1.31 (0.80-2.16) P = .0001 
5 years
10 years
Univariable analysis
IDH1/2WTIDH1MUTIDH2R140IDH2R172IDH1/2WTIDH1MUTIDH2R140IDH2R1724-way POR or HR (95% CI) (IDH2R140 vs IDH2R172 vs IDH1/2WT)
CR, % 75 81 88 48 NA NA NA NA < .0001 R140: OR = 0.41 (0.23-0.73) R172: OR = 3.15 (1.50-6.59) P < .0001 
CR/CRi, % 82 81 92 79 NA NA NA NA .03 R140: OR = 0.40 (0.20-0.81) R172: OR = 1.23 (0.49-3.05) P = .01 
RD, % 11 11 14 NA NA NA NA .11 R140: OR = 0.38 (0.15-0.96) R172: OR = 1.34 (0.46-3.90) P = .05 
ID, % NA NA NA NA .5 R140: OR = 0.50 (0.18-1.38) R172: OR = 1.01 (0.24-4.33) P = .3 
OS, % 37 38 57 24 33 34 46 .001 R140: HR = 0.65 (0.50-0.84) R172: HR = 1.40 (0.95-2.07) P = .0004 
CIR, % 50 49 28 70 51 55 35 70 .0003 R140: HR = 0.53 (0.38-0.74) R172: HR = 1.31 (0.80-2.16) P = .0001 

WT indicates wild-type; MUT, mutant; CR, compete remission; CRi, CR with incomplete hematologic recovery; RD, resistant disease; ID, induction death; NA, not applicable; OR, odds ratio; HR, hazard ratio; and CI, confidence interval.

or Create an Account

Close Modal
Close Modal